artificial intelligence in drug discovery | pharmaphorum

Friday 5 December 2025

artificial intelligence in drug discovery

News

Ex-BioMarin CEO Bienaimé re-emerges at Owkin

Just four months after ending an 18-year stint as chief executive of BioMarin, Jean-Jacques Bienaimé, has been named chairman of Owkin, a specialist in applying artificial

Digital

AI in drug discovery

AI in Drug Discovery: Day One

There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector.

News

Visual comparison of the difference in structural prediction performance of AlphaFold2 (orange) against BaseFold (cyan)

Basecamp Research unveils improved protein structure model

Basecamp Research says it has augmented the AlphaFold2 artificial intelligence tool for predicting protein structures to create a platform that is more accurate and better

Digital

healthcare data

To fight rare diseases, win the data battle first

Innovation is the key to evolution. In the pharmaceutical space, brilliant advancements have occurred with drugs with large population pools.

Digital

AI life, work, and social

Unlocking the potential of autonomous clinical research

Artificial intelligence (AI) technology has revolutionised how we approach life, work, and social interaction.

Events

P-371-AI-in-Drug-Discovery-1200x675-banner

Partner Content

SMi’s 3rd Annual AI in Drug Discovery Conference

AI in Drug Discovery